Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
- PMID: 2472189
- DOI: 10.1016/0006-8993(88)90765-2
Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
Abstract
The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor appears to play a pivotal role in enabling glutamate to express its neurotoxic potential in a variety of neurological disorders. Our results show that the transition of glutamate from neurotransmitter to neurotoxin is facilitated when cellular energy is limited in cultured cerebellar neurons. Omission of glucose, exclusion of oxygen, or inclusion of inhibitors of oxidative phosphorylation or of the sodium/potassium pump, enables the excitatory amino acids glutamate or NMDA to express their neurotoxic potential. We interpret these results as demonstrating that glucose metabolism, ATP production, and functioning Na+,K+-ATPases are necessary to generate a resting potential sufficient to maintain the voltage-dependent Mg2+ block of the NMDA receptor channel; relief of the Mg2+ block enables the excitatory amino acids to act persistently at the NMDA receptor, resulting in the opening of ion channels and subsequent neuronal damage. These findings are discussed in the context of perturbations or abnormalities which lead to decreased availability or utilization of glucose and oxygen in the brain which may trigger endogenous excitatory amino acids to become neurotoxic by this mechanism.
Similar articles
-
Energy-related neurotoxicity at the NMDA receptor: a possible role in Alzheimer's disease and related disorders.Prog Clin Biol Res. 1989;317:143-56. Prog Clin Biol Res. 1989. PMID: 2481321
-
Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage-dependent magnesium block.Brain Res. 1989 Oct 16;499(2):267-72. doi: 10.1016/0006-8993(89)90774-9. Brain Res. 1989. PMID: 2572299
-
Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease.Ann N Y Acad Sci. 1989;568:225-33. doi: 10.1111/j.1749-6632.1989.tb12512.x. Ann N Y Acad Sci. 1989. PMID: 2576506
-
Neurocytotoxicity: pharmacological implications.Fundam Clin Pharmacol. 1991;5(9):755-67. doi: 10.1111/j.1472-8206.1991.tb00765.x. Fundam Clin Pharmacol. 1991. PMID: 1686604 Review.
-
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Ann Neurol. 1992 Feb;31(2):119-30. doi: 10.1002/ana.410310202. Ann Neurol. 1992. PMID: 1349466 Review.
Cited by
-
Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.Neurochem Int. 2013 Feb;62(3):296-305. doi: 10.1016/j.neuint.2013.01.004. Epub 2013 Jan 12. Neurochem Int. 2013. PMID: 23321384 Free PMC article.
-
The energetics of Huntington's disease.Neurochem Res. 2004 Mar;29(3):531-46. doi: 10.1023/b:nere.0000014824.04728.dd. Neurochem Res. 2004. PMID: 15038601 Review.
-
Cytokine-purine interactions in behavioral depression in rats.Integr Physiol Behav Sci. 2003 Jul-Sep;38(3):189-202. doi: 10.1007/BF02688853. Integr Physiol Behav Sci. 2003. PMID: 15070082 Review.
-
AMPA prevents glutamate-induced neurotoxicity and apoptosis in cultured cerebellar granule cell neurons.Neurotox Res. 2000;2(1):51-61. doi: 10.1007/BF03033327. Neurotox Res. 2000. PMID: 15545006
-
Neurophysiology of the brain stem in Parkinson's disease.J Neurophysiol. 2019 May 1;121(5):1856-1864. doi: 10.1152/jn.00056.2019. Epub 2019 Mar 27. J Neurophysiol. 2019. PMID: 30917059 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
